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ABSTRACT 
miRNAs have been found to play a major role in cardiomyopathy, a heart muscle disorder 
characterized by cardiac dysfunction. Several miRNAs including those involved in heart de-
velopment are found to be dysregulated in cardiomyopathy. These miRNAs act either directly 
or indirectly by controlling the genes involved in normal development and functioning of the 
heart. Indirectly it also targets modifier genes and genes involved in signaling pathways. In 
this review, miRNAs involved in heart development, including dysregulation of miRNA 
which regulate various genes, modifiers and notch signaling pathway genes leading to cardi-
omyopathy are discussed. A study of these miRNAs would give an insight into the mecha-
nisms involved in the processes of heart development and disease. Apart from this, infor-
mation gathered from these studies would also generate suitable therapeutic targets in the 
form of antagomirs which are chemically engineered oligonucleotides used for silencing 
miRNAs. 
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INTRODUCTION 
Cardiomyopathy is a disease of the 
heart muscle characterized by cardiac dys-
function, arrhythmia, heart failure and sud-
den death. It is a major cause of morbidity 
and mortality worldwide. Cardiomyopathy 
can be classified into 2 major groups based 
on predominant organ involvement: Prima-
ry cardiomyopathy (genetic, nongenetic, 
acquired) are those which are confined to 
heart muscle and Secondary cardiomyopa-
thy show pathological myocardial involve-
ment as part of a large number and variety 
of generalized systemic disorders (Elliott et 
al., 2008; Maron et al., 2006).  
It is also considered as a disease of sar-
comere and cytoskeleton and recent studies 
have revealed new facets about the role of 
micro RNAs (miRNAs) in cardiac devel-
opment and remodeling. A growing body of 
exciting evidence suggests that miRNAs are 
regulators of cardiovascular cell differentia-
tion, growth, proliferation, angiogenesis 
and apoptosis. It has provided glimpses of 
undiscovered regulatory mechanisms and 
potential therapeutic targets for the treat-
ment of cardiomyopathy. 
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microRNAs 
miRNA, an endogenous ~22nt RNA, 
plays an important regulatory role in ani-
mals and plants. They cleave the target 
mRNA or translationally repress the 
mRNA. The first miRNA discovered was 
lin-4 in C. elegans, which was found to 
produce a pair of short RNA transcripts that 
regulate the timing of larval development 
by translational repression of lin-14, which 
encodes a nuclear protein (Lee et al., 1993). 
Since the discovery of let-7, miRNAs have 
been identified in organisms as diverse as 
viruses, worms, and primates through ran-
dom cloning and sequencing or computa-
tional prediction. A hepta nucleotide se-
quence at the 5’ end of the miRNA is essen-
tial in the base pairing specificity with the 
3’ end of the mRNA (Gregory et al., 2008). 
 
Role of miRNA in heart development and 
function 
Role of miRNAs in heart development 
was identified in zebrafish and mice by tar-
geting the Dicer protein which is the main 
component of miRNA machinery. Zebra-
fish lacking maternal and endogenous dicer 
exhibited heart developmental defects (Gi-
raldez et al., 2005; Wienholds et al., 2003). 
Cardiac-specific deletion of dicer in mice 
resulted in pericardial edema and poorly 
developed ventricular myocardium, result-
ing in embryonic lethality (Zhao et al., 
2007). Adult mice lacking dicer in the myo-
cardium revealed high incidence of sudden 
death due to cardiac hypertrophy and reac-
tivation of the fetal cardiac gene program 
(da Costa Martins et al., 2008). Further 
studies also showed that additional miR-
NAs, miR1, miR133, miR1/133 (bicistron-
ic), miR21 and miR138 are involved in the 
regulation of heart development. 
miR-1/miR-133: The most abundant 
miRNA in cardiac myocytes and also the 
first miRNA implicated in heart develop-
ment was miR-1(Zhao et al., 2007). miR-1 
and -133 are expressed in cardiac and skele-
tal muscles and are transcriptionally regu-
lated by the myogenic differentiation fac-
tors MyoD, Mef2, and serum response fac-
tor (SRF) (Chen et al., 2008, Kwon et al., 
2005; Lagos-Quintana et al., 2001; Rao et 
al., 2006; Sokol and Ambros, 2005; Zhao et 
al., 2005). 
Targeted deletion of the muscle-specific 
miRNA, miR-1-2, was found to cause ven-
tricular septal defects (VSD) in embryos of 
mice resulting in immediate death and/or 
pericardial edema which contributes to em-
bryonic mortality (Yu et al., 2008). In mice 
that survived postnatally, some died within 
months due to rapid dilatation of the heart 
and ventricular dysfunction, while many 
others suffered sudden cardiac death be-
cause of abnormalities in cardiac conduc-
tion and repolarization. miR-1-2 also direct-
ly targets irx5, which is known to repress 
the potassium channel, Kcnd2, ensuring co-
ordinated cardiac repolarization (Costantini 
et al., 2005). In adult miR-1-2 mutants, car-
diomyocyte division continues postnatally 
due to abnormalities in cell-cycle leading to 
hyperplasia of the heart. 
miR-1 levels are low during cardiac de-
velopment but seem to increase as devel-
opment progresses. In mice, overexpression 
of miR-1 under the control of the myosin 
heavy chain (MHC) promoter negatively 
regulates cardiac growth, by inhibiting 
translation of heart and neural crest deriva-
tive-2 protein, Hand2, which is involved in 
ventricular myocyte expansion (Zhao et al., 
2005). In drosophila, dmiR-1 plays an im-
portant role in differentiation of cardiac 
progenitor cells by targeting transcripts of 
delta, a ligand involved in Notch signaling 
pathway, which regulates the expansion of 
cardiac and muscle progenitor cells (Kwon 
et al., 2005).  
miR1/133 (bicistronic) has been found 
to enhance differentiation of mouse and 
human embryonic stem cells into mesoderm 
while suppressing their differentiation into 
neuroectoderm or endoderm. But later dur-
ing the adaptation of muscle lineage, miR-1 
and miR-133 had opposing effects, wherein 
miR-1 promotes differentiation into cardiac 
muscle fate and miR-133 blocks the cell 
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fate (Ivey et al., 2008). Stress induced 
apoptosis is provoked by increased levels of 
miR-1, and increased levels of miR-133 has 
a protective effect against cell death trig-
gered by free radicals such as hydrogen 
peroxide (Tang et al., 2009; Xu et al., 2007; 
Cheng et al., 2007). 
miR-21: Another miRNA consistently 
induced by cardiac stress is miR-21, the 
role of which is vaguely defined. This par-
ticular miRNA is stress induced and is a 
regulator of cardiac growth (Van Rooij et 
al., 2006). Hence its interaction with the 
HSP-70 gene family needs to be elucidated, 
as HSP is also a cardiac specific develop-
ment gene. Sabatel et al. (2011) showed 
that over-expression of miR-21 reduced en-
dothelial cell proliferation, migration, and 
tube formation by targeting RhoB, whereas 
knockdown of miR-21 led to an opposite 
effect.  
miR-138: miR-138 is a highly con-
served miRNA, which is found in many re-
gions of the developing embryo, but within 
the zebrafish heart, it is categorically ex-
pressed in the ventricular chamber (Morton 
et al., 2008). Changes in miR-138 function 
resulted in the expansion of the atrioven-
tricular canal into the ventricle and failure 
of maturation of ventricular cardiomyo-
cytes. It has thus been suggested that other 
region-specific miRNAs may reinforce 
known signaling and transcriptional net-
works that establish patterns of gene ex-
pression throughout the developing heart 
tube (Cordes and Srivastava 2009). Hence 
the relation between modifier genes and 
miRs during embryogenesis needs to be fo-
cused in the current research on cardiomy-
opathy. 
 
miRNA in cardiomyopathy and cardiac 
remodelling 
miRNA mediated gene repression is an 
important regulatory mechanism to modu-
late fundamental cellular processes such as 
the cell cycle, growth, proliferation, pheno-
type, death, which in turn may have major 
influence on the pathophysiological out-
comes like cardiac fibrosis, hypertrophy, 
angiogenesis, and heart failure (Catalucci et 
al., 2009; Thum et al., 2007, 2008). Alt-
hough miRNAs are highly expressed in 
heart, their role in heart diseases especially 
cardiomyopathy still remains elusive. Mul-
tiple aberrant miRNA expression is a re-
markable characteristic of the hypertrophic 
heart (Cheng et al., 2007). The dysregula-
tion and the time course changes of these 
multiple aberrantly expressed miRNAs 
match the complex process of cardiac hy-
pertrophy formation in which several genes 
have been reported to be dysregulated 
(Dorn and Hahn, 2004). Determining the 
effects of these dysregulated miRNAs in 
cardiac hypertrophy is the prerequisite for 
novel research on cardiomyopathy. It was 
reported that a cardiac-specific knockout of 
the Dicer gene leads to rapidly progressive 
dilated cardiomyopathy (DCM), heart fail-
ure, and postnatal lethality. Dicer expres-
sion decreased in end-stage DCM heart due 
to heart failure. These findings suggest that 
Dicer function and miRNAs play critical 
roles in normal cardiac function and heart 
diseases especially during heart failure 
(Chen et al., 2008). 
miR-1/miR-133: miR-133 and miR-1 
play critical roles in cardiac hypertrophy. In 
human and mouse models of cardiac hyper-
trophy, decreased expression of both miR-
133 and miR-1 is reported. Invitro, overex-
pression of miR-133 or miR-1 inhibited 
cardiac hypertrophy. In contrast, suppres-
sion of miR-133 induced hypertrophy. In 
vivo inhibition of miR-133 by a single infu-
sion of an antagomir caused marked and 
sustained cardiac hypertrophy. RhoA, a 
GDP-GTP exchange protein (regulator of 
cardiac hypertrophy); Cdc42, a signal 
transduction kinase (implicated in hyper-
trophy); and Nelf-A/WHSC2, a nuclear fac-
tor (involved in cardiogenesis) are all tar-
gets of miR-133 (Carè et al., 2007). 
When overexpressed in normal or in-
farcted rat hearts, miR-1 aggravates ar-
rhythmogenesis and elimination of miR-1 
by an antisense inhibitor relieved ar-
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rhythmogenesis. The target of miR-1 was 
found to be gap junction protein α1 (GJA1) 
which encodes Cx43, the main cardiac gap 
junction channel important for conductance 
in the ventricles (Luo et al., 2007) and po-
tassium inwardly-rectifying channel, sub-
family J, member 2 (KCNJ2) (Yang et al., 
2007). 
miR-21: Inhibition of miR-21 in neona-
tal rat cardiomyocytes by transfecting 
locked nucleic acid (LNA)-modified anti-
sense oligonucleotides (miR-LNA) to miR-
21 or miR-18b induced myocyte hypertro-
phy while transfection of miR-21 and miR-
18b duplexes slightly decreased cardiomy-
ocyte size and decreased hypertrophy, thus 
suggesting their role in regulating cardio-
myocyte hypertrophy. The molecular basis 
of such regulation still needs to be estab-
lished. Hence the role of miR-21 in chro-
matin modelling of cardiomyocytes cannot 
be overlooked (Tatsuguchi et al., 2007). 
A study showed an increased expression 
of miR-21, miR-23, miR-24, miR-125b, 
miR-195, miR-199a, and miR-214, and de-
creased expression of miR-29c, miR-93, 
miR-150, and miR-181b in mice subjected 
to chemicals which induced cardiac hyper-
trophy. Upon transfection into cardiomyo-
cytes, five of the miRNAs that were upreg-
ulated, viz. miR-23a, miR-23b, miR-24, 
miR-195, and miR-214, were found to be 
capable of inducing hypertrophic growth. 
Whereas transfection of miR-199a resulted 
in elongated spindle shapes myocytes remi-
niscent of the elongated cardiac myocytes 
observed in dilated cardiomyopathy 
(DCM). 
Cardiac specific overexpression of miR-
195 was found to cause death in the first 2 
weeks after birth due to heart failure associ-
ated with cardiac dilatation and in the rats 
that survived initially, induction of cardiac 
growth with disorganization of cardiomyo-
cytes occurred at 2 weeks of age, which lat-
er progressed to a dilated cardiac hyper-
trophic phenotype by 6 weeks of age thus 
suggesting the critical role played by miR-
195 in cardiac remodeling (Van Rooij et al., 
2006).  
miR-29: The miR-29 family, which is 
downregulated after myocardial infarction, 
inhibits expression of several collagens and 
extracellular matrix proteins, thereby con-
tributing to scar formation and fibrosis, as 
seen in DCM, during heart failure.  
miR-208: miR-208 is required for the 
development of cardiac hypertrophy and 
myocardial fibrosis and it is also a positive 
regulator of MHC gene expression (van 
Rooij et al., 2007). 
 
Regulation of modifiers by miRNAs 
Stress is a major etiologic factor that 
may contribute to heart diseases. Stress 
overload can cause tissue injury and cardi-
omyocyte death is considered an important 
cellular basis for stress-induced injury in 
cardiomyopathy (Feuerstein and Young 
2000). miR-199 family is rapidly downreg-
ulated in cardiac myocytes under hypoxic 
conditions, relieving the repression of 
sirtuin 1 and hypoxia inducible factor 1-α in 
a model of hypoxia preconditioning. The 
miRNA that repeatedly showed dynamic 
regulation after cellular stress is miR-21, 
which promotes cardiac hypertrophy and 
fibrosis in response to pressure overload 
(Rane et al., 2009).  
Under stress, a change in expression of 
HSP70 in rat myocardium is observed. 
HSP70 protects cardiomyocyte from stress 
induced injury by inhibiting Fas-mediated 
apoptosis (Basu et al., 2001). Levels of 
miR-1 were found to increase significantly 
in response to oxidative stress which later 
reduced the levels of HSP70 favoring car-
diomyocyte apoptosis, while decreased lev-
els of miR-1 favored cardiomyocyte surviv-
al (Xu et al., 2007). Members of TGF-β 
family also have been found to have a car-
dioprotective role and are highly induced in 
affected hearts. Their putative roles during 
atherogenesis, infarct healing, cardiac re-
pair and left ventricular remodeling have 
been proposed (Os et al., 2002). miR24a 
and miR34a seem to have a strong and spe-
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cific regulatory effect on TGF β while miR-
373 and miR-34b have a constitutive role 
(Schultz et al., 2011). The renin-angiotensin 
system (RAS) is one of the most important 
modifiers in cardiomyopathy. The angio-
tensin converting enzyme (ACE) is the key 
enzyme, involved in conversion of angio-
tensin I to angiotensin II which is responsi-
ble for cardiac hypertrophy and heart fail-
ure (Kawaguchi, 2003) and miR145 has 
been found to regulate this enzyme (Small 
et al., 2010). Thus it can be deliberated that 
diseased phenotype is influenced by either 
cytoskeletal/sarcomeric genes, modifiers, 
and/or miRNAs controlling these genes. 
Hence it can be hypothesized that miR-
NAs have both positive and negative roles 
in cardiomyopathy, especially with respect 
to a heart failure phenotype; either as modi-
fiers or by gene-gene interaction and/or 
regulators of cardiogenesis. One such regu-
lation could be in the signaling/transduction 
pathways controlled by the miR’s. 
 
Regulation of signaling pathways by  
miRNAs and their role in cardio-
myopathies 
Understanding complex diseases like 
cardiomyopathy not only requires identifi-
cation of genes and upregulation/ downreg-
ulation of miRNAs, but also of the proteins 
that are regulated and signaling pathways 
that are affected by these miRNAs. Various 
intercellular signaling pathways have been 
implicated in the control of cardiogenesis 
viz. Notch signaling, FGF signaling, BMP 
signaling, Wnt/β-catenin signaling, Wnt/ 
JNK pathways etc. 
 
(I) Notch signaling and cardiogenesis: 
Notch signaling mediates numerous de-
velopmental cell fate decisions in organ-
isms ranging from flies to humans, resulting 
in the generation of multiple cell types from 
equipotential precursors. Notch signaling is 
also involved in angiogenesis and vasculo-
genesis. Notch signaling is a highly con-
served and a complex mechanism initiated 
by the interaction of Notch receptors with 
their ligands both of which are transmem-
brane proteins whose extracellular domains 
are composed of epidermal growth factor 
(EGF) like repeats (Eiraku et al., 2005). 
The Notch receptors include the Notch1-4 
in mammals and Notch in drosophila. The 
Notch ligands include classical ligands such 
as Jagged – Jag1 and Jag2 - and Delta-like - 
DLL1, DLL3 and DLL4 and atypical lig-
ands DNER, F3/Contactin1, NB-3/Contac-
tin6 and Delta-like 1 homologue. The 
Notch pathway is intricately involved in the 
development of the cardiovascular system. 
One of the major functions of Notch signal-
ing is its ability to influence cell fate deci-
sions during development (Kwon et al., 
2005). Several of the Notch pathway com-
ponents have been linked to the vascular 
system development, including Jagged1, 
Notch1, Notch2, Notch4 and presenilin (Ei-
raku et al., 2005; Bray et al., 2008). The 
Notch1 receptor is responsible for the 
blockade of cardiogenesis. Notch1 is also 
involved in the suppression of cardiomyo-
cyte differentiation. It has also been pro-
posed that inhibition of cardiogenesis by 
Notch signaling is carried out by blocking 
mesodermal differentiation (Sethupathy et 
al., 2006). Hence Notch signaling pathway, 
known to influence cardiogenesis and heart 
development, in conjunction with miRNAs, 
needs to be elucidated. 
 
Notch signaling and miRNA in  
cardiomyopathy 
miRNA regulation is essential for nor-
mal Notch signaling. Default repression by 
miRNAs does not necessarily have to target 
core pathway components; it may be equal-
ly effective when it intercepts their tran-
scriptional targets as shown by the default 
repression of the E (spl) and Bearded (Brd) 
gene clusters whose activation is dependent 
on signaling by Notch in Drosophila. This 
is a highly redundant system, in which fam-
ilies of related miRNAs (miR-2, miR-4, 
miR-7, miR-11 and miR-79) promiscuously 
target a family of related mRNAs, prevent-
ing aberrant deployment of Notch-mediated 
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developmental programmes (Sabatel et al., 
2011). Regulation of the expansion of car-
diac and muscle progenitor cells is carried 
out by the notch ligand Delta, and this is 
targeted for repression by dmiR-1 (Kwon et 
al., 2005). Several conserved putative miR-
1-binding sites were found in the 3’-UTR of 
the gene encoding Delta (Artavanis-
Tsakonas et al., 1999). It was also found 
that miR-1 fine-tunes Notch ligand Delta 
that is critically involved in differentiation 
of cardiac and somatic muscle progenitors 
and targets a pathway essential for progeni-
tor cell specification and asymmetric cell 
division. Introduction of miR-133 allows 
cardiac tissue formation, but the tissue is 
disorganized and does not lead to chamber 
formation. It has thus been shown that miR-
1 and miR-133 function antagonistically to 
each other whenever miR-1 shifts the de-
velopment of the stem cells towards a car-
diac fate and miR-133 inhibits this event. 
The cardiac fate achieved by miR-1 is by 
transcriptional repression of Dll-1, which is 
the mammalian ortholog of Delta in Dro-
sophila (Atsuhiko et al., 2011). It has also 
been reported that the members of the Hairy 
family, particularly Hrt2/Hey2, involved in 
heart disease, are themselves regulated by 
miR-1-2 and members of the Hairy family 
are transcriptional repressors which mediate 
Notch signaling. The effect produced by 
miR-1-2 on Hey2 is also seen on Hand1, 
involved in Notch pathway, which is a 
bHLH transcription factor involved in ven-
tricular development and septation that, in 
combination with Hand2 (a paralog of 
Hand1), is known to regulate expansion of 
the embryonic cardiac ventricles (Kwon et 
al., 2005; Jiang et al., 2009; Rusconi and 
Corbin, 1998; Sabatel et al., 2011; Sapir et 
al., 2005). miR-1-2 appears to be involved 
in the regulation of diverse cardiac and 
skeletal muscle functions, including cellular 
proliferation, differentiation, cardiomyocyte 
hypertrophy, cardiac conduction and ar-
rhythmias (Han and Bodmer, 2003). Hence 
studying miRs regulating the Notch signal-
ing pathway involved in cardiac develop-
ment, differentiation and ultimately cardi-
omyopathy needs to be emphasized.  
 
(II) Wnt/β-catenin and Wnt/JNK signaling 
in cardiogenesis 
Wnt proteins are secreted glycoproteins 
which upon binding to Frizzled family re-
ceptors and several coreceptors such as lip-
oprotein receptor-related protein (LRP)-5/6, 
Ryk, or Ror2, activates intracellular signal 
transduction. Some aspects of cell cycle, 
differentiation and proliferation are de-
pendent on regulation of gene expression 
by Wnt proteins. Cell adhesion requires the 
interaction of β-catenin with cadherins by 
establishing a link to the actin cytoskeleton 
(Rao and Kühl, 2010). During early embry-
onic development of zebrafish, the Wnt/ β-
catenin pathway induces the formation of 
the lateral mesoderm, whereas its negative 
role/repressive activity helps to define the 
proper size of the heart-forming field (Ta-
zhor, 2007).  
Depending on the major intracellular 
mediators, Wnt/jun N-terminal kinase 
(JNK) or Wnt/calcium pathways, which are 
independent of β-catenin are activated. Ac-
tivation of small GTPases of the rho family 
including rac, cdc42, and rho and other 
downstream protein kinases such as JNK or 
rho kinase is involved in the Wnt/JNK 
pathway. Dkk1, a target gene of Wnt/β-
catenin signaling establishes a negative-
feedback loop by way of inhibiting the ca-
nonical Wnt pathway. The N-terminal do-
main of Dkk1 may be involved in regulat-
ing cardiogenesis, in a β-catenin independ-
ent fashion (Korol et al., 2008). 
 
miRNA and Wnt signaling 
β-catenin dependent transcription is 
down regulated by miR-200a by two differ-
ent mechanisms. MiR-200a induces cell-
cell adhesion by increasing the level of E-
cadherin, via targeting the mRNA of the E-
cadherin repressor proteins ZEB1 and 
ZEB2 (Korpal et al., 2008). Following 
which, β-catenin is marked for degradation 
by ubiquitin/proteasome system through 
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phosphorylation at Ser33, Ser 37, Thr 41 
and Ser45 (Burk et al., 2008). Another 
mechanism of downregulation of β-catenin 
activity by miR-200a was recently proposed 
in meningiomas. MiR-200a regulates β-
catenin expression and subsequent activa-
tion of Wnt/ β-catenin signaling by directly 
targeting the 3’UTR of β-catenin mRNA. 
Other members of miR-200 family, viz. 
miR-200b and miR-200c have no effect in 
this domain (Saydam et al., 2009). 
MiR-135a and miR-135b stabilize β-
catenin and thus activate Wnt signaling by 
suppressing APC expression (Nagel et al., 
2008). MiR-315 directly targets Axin and 
Notum, two negative regulators of Wg sig-
naling, in Drosophila cells, resulting in Wnt 
pathway activation (Silver et al., 2007; 
Huang K et al., 2010). 
Thus it can be said that MiRNAs indi-
rectly regulate cardiogenesis by way of β-
catenin in WNT signaling.  
 
(III) FGF and BMP signaling in cardio-
genesis 
Fibroblast Growth Factor (FGF) and 
Bone Morphogenetic Proteins (BMP's) are 
cardiogenic inducers. FGFs are involved in 
the induction and patterning of the meso-
derm and their role in cardiogenic induction 
involves synergistic interaction with BMP 
signaling pathways. The need for both BMP 
and FGF in cardiac induction was revealed 
in experiments showing that BMP-2 alone 
could not promote survival of precardiac or 
non-precardiac mesoderm cells in culture, 
whereas FGF-4 could support and maintain 
cardiogenesis in precardiac mesoderm, alt-
hough it lacked the ability to induce cardi-
ogenesis in non-precardiac mesoderm 
(Wagner and Siddiqui, 2007). 
While BMP and FGF pathways are im-
plicated in promoting cardiac induction, 
there is evidence that Wnt antagonism sti-
mulates cardiogenesis in chick and Xenopus 
embryos. In apparent contrast, Wnt/β-
catenin signaling promotes cardiogenesis in 
ES cells if activated early, but opposes it 
when activated after specification (Samuel 
and Latinkic, 2009). 
 
miRNA in FGF and BMP signaling 
BMP-2 increases Runx2 expression 
which results in increased expression of the 
Runx2‐dependent genes osteopontin and 
osteocalcin, increased intracellular Ca2+ 
deposition, and calcification of human cor-
onary artery smooth muscle cells 
(CASMCs). BMP‐2 downregulates miR‐
30b and miR‐30c to increase Runx2 protein 
expression and vascular calcification. In 
C2C12 cells, BMP‐2 promotes osteogenic 
differentiation by decreasing miR‐133 ex-
pression to increase Runx2 as well as 
downregulating miR‐206 expression to lim-
it the expression of myogenic differentia-
tion marker proteins. BMP‐2 was also 
shown to regulate Runx2 expression by up-
regulating miR‐3960 expression which re-
sulted in decreased expression of homeobox 
A2, a repressor of Runx2 expression (Bal-
derman et al., 2012). 
BMP signaling regulates the miRNA-
17-92 complex through Smad-mediated pri-
miRNA transcriptional activation to control 
a pathway promoting SHF myocardial dif-
ferentiation. Other important cardiovascular 
miRNAs, such as miRNA-143 and miRNA-
145, are downregulated in BMP 2/4 CKO 
mutants but some other miRNAs are upreg-
ulated suggesting that BMP signaling likely 
regulates multiple events in cardiac devel-
opment through miRNA effector pathways. 
Bmp2 and Bmp4 regulate OFT (outflow 
tract) myocardial differentiation via regula-
tion of the miRNA-17-92 cluster. In BMP 
mutant embryos, myocardial differentiation 
was delayed, and multiple miRNAs encod-
ed by miRNA-17-92 were reduced. Genetic 
interaction studies uncovered a synergistic 
interaction between miRNA-17-92 cluster 
and BMP 4, providing direct in vivo evi-
dence for the BMP-miRNA-17-92 regulato-
ry pathway. These findings indicate that 
BMP signaling directly regulates a miRNA-
mediated effector mechanism via downreg-
ulation of cardiac progenitor genes and en-
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hancement of myocardial differentiation 
(Wang et al., 2010). 
Potent angiogenic growth factors, such 
as VEGF and FGF, are required for neoan-
giogenesis during embryogenesis and 
adulthood. miR-126 which is an endothelial 
cell-specific miRNA, modulates angiogene-
sis in vivo, but in a subset of mutant mice, 
targeted deletion of miR-126 resulted in 
vascular leakage, hemorrhaging, and em-
bryonic lethality, and these aftereffects can 
be attributed to reduced angiogenic growth 
factor signaling. The proangiogenic action 
of miR-126 correlates with its repression of 
Spred-1, a negative regulator of MAP ki-
nase signaling. Hence decline in the trans-
mission of intracellular angiogenic signals 
by VEGF and FGF culminated because of 
increased expression of Spred-1 in the ab-
sence of miR-126. Hence it can be conclud-
ed that miR-126 functions as an endothelial 
cell-specific regulator of angiogenic signal-
ing. The vascular abnormalities of miR-126 
mutant mice simulate the outcome of de-
creased signaling by angiogenic growth fac-
tors, such as VEGF and FGF. miR-126 
augments the proangiogenic actions of 
VEGF and FGF and promotes blood vessel 
formation by repressing the expression of 
Spred-1, an intracellular inhibitor of angio-
genic signaling. These findings will help in 
improvising the current therapeutics for a 
variety of disorders involving abnormal an-
giogenesis and vascular leakage. miR-126 
is required for vascular integrity and angio-
genesis, as well as survival post-Myocardial 
Infarction and its potential for augmenting 
cardiac repair needs to be utilized. Dimin-
ishing miR-126 expression may be effica-
cious in settings of pathological vasculari-
zation, such as cancer, atherosclerosis, reti-
nopathy and stroke. Thus strategies to pro-
mote miR-126 in the ischemic myocardium 
which could intensify cardiac repair need to 
be devised. Hence the exact role of miR-
126 and associated miRNAs in cardiac re-
pair needs to be elucidated to understand 
their functioning in tissue remodeling and 
diseases (Wang et al., 2008). A brief sum-
mary of the miRNAs with their various 
functions is given in Table 1. 
Table 1: List of miRNAs and their functions 
miRNA Functions 
miR-1/miR-133 Involved in cardiac con-
duction and repolariza-
tion, differentiation into 
cardiac muscle fate and 
Stress induced apoptosis 
Play important roles dur-
ing induction of hypertro-
phy and arrhythmias. 
Involved in Notch signal-
ing by regulating Delta 
miR-21 Regulates cardiac 
growth 
Involved in induction of 
hypertrophy 
miR-29 Contributes to scar for-
mation and fibrosis 
miR-138 Involved in remodeling of 
Atrio-ventricular canal 
miR-208 Involved in hypertrophy 
and fibrosis 
miR-200a Downregulates β-
catenin-mediated tran-
scription and induces the 
cell-cell adhesion com-
plex 
miR-8 Promote adipogenesis 
by inhibiting Wg signal-
ing 
miR‐3960 Calcification of CASMCs 
by regulating Runx2 
miR-126 Endothelial cell-specific 
regulator of angiogenic 
signaling 
 
CONCLUSION 
In the preceding discussion, the in-
volvement of miRNAs in regulating devel-
opmental processes in the heart and their 
involvement in cardiomyopathy via sarco-
meric genes, modifiers and signaling path-
ways such as the Notch pathway is re-
viewed. Mutations in sarcomeric genes are 
the primary causatives of the disease, 
whereas the modifiers determine the severi-
ty. 
The miRNAs regulating these genes 
thus play an important role in development 
and disease. The roles played by several 
miRNAs have been elucidated, but an in 
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depth analysis of the miRNAs, and the 
genes that encode them and also the genes 
targeted by them is essential to bring for-
ward the complex interplay that occurs dur-
ing development and disease causation. 
Notch pathway is involved in the develop-
ment of cardiovascular system, as it pro-
motes cell proliferation and apoptosis. 
Many miRNAs are known to regulate the 
Notch pathway and the dysregulation of 
these miRNA affects cell proliferation, dif-
ferentiation, cardiac conduction, leading to 
cardiac hypertrophy and arrhythmias. But 
the information available in this context is 
still obscure. Further studies are necessary 
to identify other miRNAs involved in regu-
lation of notch pathway. The effect of 
miRNA regulation through WNT signaling 
pathway is evident only through its control 
of β-catenin, other dimensions are yet to be 
discovered. The BMP-FGF pathways is im-
portant in subsidiary processes of cardi-
ogenesis such as myocardial differentiation 
and angiogenesis, indicating the role of 
miRNA in the regulation of these pathways. 
A study of miRNAs would also give us po-
tential therapeutic targets in the form of an-
tagomirs which are used for silencing 
miRNAs that are implicated in the manifes-
tation of cardiomyopathy. Complete revela-
tion of the roles played by miRNA may 
give crucial insights into many of the mys-
teries of the human heart and CVD’s and 
taking into view the benefits of these miR-
NA’s and associated pathways, miRNA-
based therapies may pave the way for the 
treatment of cardiomyopathy.  
 
REFERENCES 
Artavanis-Tsakonas S, Rand MD, Lake RJ. 
Notch signaling: cell fate control and signal 
integration in development. Science 1999; 
284:770–6. 
 
Atsuhiko I, Yoshinao, Kazuya T, Gozoh T. 
miRNAs and regulation of cell signalling. 
FEBS 2011;278:1610–8.  
 
Balderman JA, Lee HY, Mahoney CE, 
Handy DE, White K, Annis S et al. Bone 
morphogenetic protein‐2 decreases micro-
RNA‐30b and microRNA‐30c to promote 
vascular smooth muscle cell calcification. J 
Am Heart Assoc 2012;1:e003905. 
 
Basu N, Nakano T, Grau EG, Iwama GK. 
The effects of cortisol on heat shock protein 
70 levels in two fish species. Gen Com En-
docrinol 2001;124:97-105. 
 
Bray SJ, Takada S, Harrison E, Shen SC, 
Ferguson-Smith A. The atypical mammali-
an ligand Delta-like1 (Dlk1) can regulate 
Notch signalling in Drosophila. BMC Dev 
Biol 2008;8:11. 
 
Burk U, Schubert J, Wellner U, Schmalho-
fer O, Vincan, Spaderna S et al. A recipro-
cal repression between ZEB1 and members 
of the miR-200 family promotes EMT and 
invasion in cancer cells. EMBO Rep 2008; 
9:582-9. 
 
Carè A, Catalucci D, Felicetti F, Bonci D, 
Addario A, Gallo P et al. MicroRNA-133 
controls cardiac hypertrophy. Nature Med 
2007;13:613-8. 
 
Catalucci D, Gallo P, Condorelli G. Mi-
croRNAs in cardiovascular biology and 
heart disease. Circ Cardiovasc Genet 2009; 
2:402-8. 
 
Chen JF, Murchison EP, Tang R, Callis TE, 
Tatsuguchi M, Deng Z et al. Targeted dele-
tion of dicer in the heart leads to dilated 
cardiomyopathy and heart failure. Proc Natl 
Acad Sci U S A 2008;105:2111-6. 
 
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen 
H et al. MicroRNAs are aberrantly expres-
sed in hypertrophic heart: do they play a 
role in cardiac hypertrophy? Am J Pathol 
2007;170:1831-40. 
 
EXCLI Journal 2013;12:980-992 – ISSN 1611-2156 
Received: September 23, 2013, accepted: November 07, 2013, published: November 26, 2013 
 
 
 
989 
Cordes KR, Srivastava D. MicroRNA regu-
lation of cardiovascular development. Circ 
Res 2009;104:724-32. 
 
Costantini DL, Arruda EP, Agarwal P, Kim 
KH, Zhu Y, Zhu W et al. The homeodo-
main transcription factor Irx5 establishes 
the mouse cardiac ventricular repolarization 
gradient. Cell 2005;123:347-58. 
 
da Costa Martins PA, Bourajjaj M, Gladka 
M, Kortland M, van Oort RJ, Pinto YM et 
al. Conditional dicer gene deletion in the 
postnatal myocardium provokes spontane-
ous cardiac remodeling. Circulation 2008; 
118:1567-76. 
 
Dorn II GW, Hahn HS. Genetic factors in 
cardiac hypertrophy. Ann NY Acad Sci 
2004;1015:225-37. 
 
Eiraku M, Tohgo A, Ono K, Kaneko M, 
Fujishima K, Hirano T et al. DNER acts as 
a neuron-specific Notch ligand during 
Bergmann glial development. Nature Neu-
rosci 2005;8:873-80. 
 
Elliott P, Andersson B, Arbustini E, Bilin-
ska Z, Cecchi F, Charron P et al. Classifica-
tion of the cardiomyopathies: a position 
statement from the European Society of 
Cardiology Working Group on Myocardial 
and Pericardial Diseases. Eur Heart J 2008; 
29:270-6. 
 
Feuerstein GZ, Young PR. Apoptosis in 
cardiac diseases: stress- and mitogen-
activated signaling pathways. Cardiovasc 
Res 2000;45:560-9. 
 
Giraldez AJ, Cinalli RM, Glasner ME, En-
right AJ, Thomson JM, Baskerville S et al. 
MicroRNAs regulate brain morphogenesis 
in zebrafish. Science 2005;308:833-88.  
 
Gregory PA, Bert AG, Paterson EL, Barry 
SC, Tsykin A, Farshid G et al. The miR-
200 family and miR-205 regulate epithelial 
to mesenchymal transition by targeting 
ZEB1 and SIP1. Naure Cell Biol 2008;10: 
593-601. 
 
Han Z, Bodmer R. Myogenic cells fates are 
antagonized by Notch only in asymmetric 
lineages of the Drosophila heart, with or 
without cell division. Development 
2003;130:3039-51. 
 
Huang K, Zhang J, Han L, You Y, Jiang T, 
Pu P et al. MicroRNA roles in beta-catenin 
pathway. Mol Cancer 2010;9:252. 
 
Ivey KN, Muth A, Arnold J, King FW, Yeh 
RF, Fish JE et al. MicroRNA regulation of 
cell lineages in mouse and human embryon-
ic stem cells. Cell Stem Cell 2008;2:219-29  
 
Jiang Q, Wang Y, Hao Y, Juan L, Teng M, 
Zhang X et al. miR2disease: a manually cu-
rated database for microRNA deregulation 
in human disease. Nucleic Acids Res 
2009;37(Database issue):D98–D104. 
 
Kawaguchi H. Angiotensin-converting en-
zyme and angiotensinogen gene polymor-
phism in hypertrophic cardiomyopathy. Exp 
Clin Cardiol 2003;8:155-9.  
 
Korol O, Gupta RW, Mercola M. A novel 
activity of the Dickkopf-1 amino terminal 
domain promotes axial and heart develop-
ment independently of canonical Wnt inhi-
bition. Dev Biol 2008;324:131-8. 
 
Korpal M, Lee ES, Hu G, Kang Y. The 
miR-200 family inhibits epithelial-mes-
enchymal transition and cancer cell migra-
tion by direct targeting of E-cadherin tran-
scriptional repressors ZEB1 and ZEB2. J 
Biol Chem 2008;283:14910-4. 
 
Kwon C, Han Z, Olson EN, Srivastava D. 
MicroRNA1 influences cardiac differentia-
tion in Drosophila and regulates Notch sig-
nalling. PNAS 2005;102:18986-91. 
 
Lagos-Quintana M, Rauhut R, Lendeckel 
W, Tuschl T. Identification of novel genes 
EXCLI Journal 2013;12:980-992 – ISSN 1611-2156 
Received: September 23, 2013, accepted: November 07, 2013, published: November 26, 2013 
 
 
 
990 
coding for small expressed RNAs. Science 
2001;294:853-8. 
 
Lee RC, Feinbaum RL, Ambros V. The C. 
elegans heterochronic gene lin-4 encodes 
small RNAs with antisense complementari-
ty to lin-14. Cell 1993;75:843–54. 
 
Luo X, Xiao J, Lin H, Li B, Lu Y, Yang B 
et al. Transcriptional activation by stimulat-
ing protein 1 and post-transcriptional re-
pression by muscle-specific microRNAs of 
IKs-encoding genes and potential implica-
tions in regional heterogeneity of their ex-
pressions. J Cell Physiol 2007;212:358-67. 
 
Maron BJ, Towbin JA, Thiene G, Ant-
zelevitch C, Corrado D, Arnett D et al. 
Contemporary definitions and classification 
of the cardiomyopathies: an American 
Heart Association Scientific Statement 
from the Council on Clinical Cardiology, 
Heart Failure and Transplantation Commit-
tee; Quality of Care and Outcomes Re-
search and Functional Genomics and Trans-
lational Biology Interdisciplinary Working 
Groups; and Council on Epidemiology and 
Prevention. Circulation 2006;113:1807-16. 
 
Morton SU, Scherz PJ, Cordes KR, Ivey 
KN, Stainier DYR, Srivastava D. mi-
croRNA-138 modulates cardiac patterning 
during embryonic development. Proc Natl 
Acad Sci 2008;105:17830-5. 
 
Nagel R, le Sage C, Diosdado B, van der 
Waal M, Oude Vrielink JA, Bolijn A et al. 
Regulation of the adenomatous polyposis 
coli gene by the miR-135 family in colorec-
tal cancer. Cancer Res 2008;68:5795-802. 
 
Os I, Djurovic S, Seljeflot I, Berg K. Trans-
forming growth factor (TGF)-b1 inversely 
related to vascular cell adhesion molecule-1 
in postmenopausal women with coronary 
artery disease. A possible mechanism for 
the putative cardioprotective role of TGF-
b1? J Intern Med 2002;251:223-7. 
 
Rane S, He M, Sayed D, Vashistha H, Mal-
hotra A, Sadoshima J et al. Downregulation 
of miR-199a derepresses hypoxia-inducible 
factor-1alpha and Sirtuin 1 and recapitu-
lates hypoxia preconditioning in cardiac 
myocytes. Circ Res 2009;104:879-86. 
 
Rao PK, Kumar RM, Farkhondeh M, Bas-
kerville S, Lodish HF. Myogenic factors 
that regulate expression of muscle-specific 
microRNAs. Proc Natl Acad Sci USA 
2006;103:8721-6. 
 
Rao TP, Kühl M. An updated overview on 
Wnt signaling pathways: a prelude for 
more. Circ Res 2010;106:1798-806. 
 
Rusconi JC, Corbin V. Evidence for a novel 
Notch pathway required for muscle precur-
sor selection in Drosophila. Mech Dev 
1998;79:39-50. 
 
Sabatel C, Malvaux L, Bovy N, Deroanne 
C, Lambert V, Gonzalez ML et al. Mi-
croRNA-21 exhibits antiangiogenic func-
tion by targeting RhoB expression in endo-
thelial cells. PLoS One 2011;6:e16979. 
 
Samuel LJ, Latinkic BV. Early activation of 
FGF and nodal pathways mediates cardiac 
specification independently of Wnt/b-
catenin signaling. PLoS One 2009;4: e7650. 
 
Sapir A, Assa-Kunik E, Tsruya R, Schejter 
E, Shilo BZ. Unidirectional Notch signaling 
depends on continuous cleavage of Delta. 
Development 2005;132:123-32. 
 
Saydam O, Shen Y, Würdinger T, Senol O, 
Boke E, James MF et al. Downregulated 
microRNA-200a in meningiomas promotes 
tumor growth by reducing E-cadherin and 
activating the Wnt/β-catenin signaling path-
way. Mol Cell Biol 2009;21:5923-40. 
 
EXCLI Journal 2013;12:980-992 – ISSN 1611-2156 
Received: September 23, 2013, accepted: November 07, 2013, published: November 26, 2013 
 
 
 
991 
Schultz N, Marenstein DR, De Angelis DA, 
Wang W, Nelander S, Jacobsen A et al. 
Off-target effects dominate a large-scale 
RNAi screen for modulators of the TGF-b 
pathway and reveal microRNA regulation 
of TGFBR2. Silence 2011;2:3. 
 
Sethupathy P, Megraw M, Hatzigeorgiou 
AG. A guide through present computational 
approaches for the identification of mam-
malian microRNA targets. Nature Methods 
2006;3:881-6. 
 
Silver SJ, Hagen JW, Okamura K, Perrimon 
N, Lai EC. Functional screening identifies 
miR‐315 as a potent activator of wingless 
signaling. Proc Natl Acad Sci USA 2007; 
104:18151-6. 
 
Small EM, Frost RJ, Olson EN. Micro-
RNAs add a new dimension to cardiovascu-
lar disease. Circulation 2010;121:1022-32. 
 
Sokol NS, Ambros V. Mesodermally ex-
pressed Drosophila microRNA-1 is regulat-
ed by Twist and is required in muscles dur-
ing larval growth. Genes Dev 2005;19: 
2343-54. 
 
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, 
Huang G. MicroRNA-1 regulates cardio-
myocyte apoptosis by targeting Bcl-2. Int 
Heart J 2009;50:377-87. 
 
Tatsuguchi M, Seok HY, Callis TE, Thom-
son JM, Chen JF, Newman M et al. Expres-
sion of microRNAs is dynamically regulat-
ed during cardiomyocyte hypertrophy. J 
Mol Cell Cardiol 2007;42:1137-41. 
 
Tazhor E. Wnt/b-catenin signaling and car-
diogenesis: timing does matter.  Develop-
mental Cell 2007;13:10-3. 
 
Thum T, Galuppo P, Wolf C, Fiedler J, 
Kneitz S, van Laake LW et al. MicroRNAs 
in the human heart: a clue to fetal gene re-
programming in heart failure. Circulation 
2007;116:258-67. 
Thum T, Gross C, Fiedler J, Fischer T, 
Kissler S, Bussen M et al. MicroRNA-21 
contributes to myocardial disease by stimu-
lating MAP kinase signalling in fibroblasts. 
Nature 2008;456:980-4. 
 
van Rooij E, Sutherland LB, Liu N, Wil-
liams AH, McAnally J, Gerard RD et al. A 
signature pattern of stress-responsive mi-
croRNAs that can evoke cardiac hypertro-
phy and heart failure. Proc Natl Acad Sci 
USA 2006;28:103:18255-60. 
 
van Rooij E, Sutherland LB, Qi X, Richard-
son JA, Hill J, Olson EN. Control of stress-
dependent cardiac growth and gene expres-
sion by a MicroRNA. Science 2007;316: 
575-9. 
 
Wagner M, Siddiqui MAQ. Signal trans-
duction in early heart development (I): Car-
diogenic induction and heart tube for-
mation. Exp Biol Med 2007;232:852-65. 
 
Wang S, Aurora AB, Johnson BA, Qi X, 
McAnally J, Hill JA et al. The endothelial-
specific microRNA miR-126 governs vas-
cular integrity and angiogenesis. Dev Cell 
2008;15:261-71. 
 
Wang J, Greene SB, Bonilla-Claudio M, 
Tao Y, Zhang J, Bai Y et al. Bmp signaling 
regulates myocardial differentiation from 
cardiac progenitors through a MicroRNA-
mediated mechanism. Dev Cell 2010;19: 
903-12. 
 
Wienholds E, Koudijs MJ, van Eeden FJ, 
Cuppen E, Plasterk RH. The microRNA-
producing enzyme Dicer1 is essential for 
zebrafish development. Nature Genet 2003; 
35: 217-8. 
 
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H 
et al. The muscle-specific microRNAs miR-
1 and miR-133 produce opposing effects on 
apoptosis by targeting HSP60, HSP70 and 
caspase-9 in cardiomyocytes. J Cell Sci 
2007;120:3045-52. 
EXCLI Journal 2013;12:980-992 – ISSN 1611-2156 
Received: September 23, 2013, accepted: November 07, 2013, published: November 26, 2013 
 
 
 
992 
Yang B, Lim H, Xiao J, Lu Y, Luo X, Li B 
et al. The muscle-specific microRNA miR-
1 regulates cardiac arrhythmogenic poten-
tial by targeting GJA1 and KCNJ2. Nature 
Med 2007;13:486-91.  
 
Yu XY, Song YH, Geng YJ, Lin QX, Shan 
ZX, Lin SG et al. Glucose induces apopto-
sis of cardiomyocytes via microRNA-1 and 
IGF-1. Biochem Biophys Res Commun 
2008;376:548-52. 
 
Zhao Y, Samal E, Srivastava D. Serum re-
sponse factor regulates a muscle-specific 
microRNA that targets Hand2 during cardi-
ogenesis. Nature 2005;436:214-20. 
 
Zhao Y, Ransom JF, Li A, Vedantham V, 
von Drehle M, Muth AN et al. Dysregula-
tion of cardiogenesis, cardiac conduction, 
and cell cycle in mice lacking miRNA-1-2. 
Cell 2007;129:303-17. 
